Cyclacel Pharmaceuticals (CYCC) Competitor Comparison
We are evaluating the key criteria listed to compare Cyclacel Pharmaceuticals (CYCC) against its competitors in the Biotechnology industry.
Market Capitalization
366 / 368Gross Profits
0 / 278Total Revenue
255 / 300EBITDA
106 / 337Free Cashflow
111 / 352Quick Ratio
326 / 357Earnings per Share
345 / 359Dividend yield
0 / 6Total Cash
333 / 358Performance 3 years
364 / 368Performance 5 years
360 / 368Performance 10 years
364 / 368Linearity 3 years
293 / 368Linearity 5 years
238 / 368Linearity 10 years
317 / 368Total Rank
24 / 368Dividend Rank
4 / 368Valuation Rank
326 / 368Piotroski Rank
18 / 368Muliplier Rank
15 / 368Dividend Rank - CYCC ranking 4 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.